Beth Y. Karlan, MD
Director, Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute
Director, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology
Director, Gilda Radner Hereditary Cancer Program
Board of Governors Chair in Gynecologic Oncology
Phone: (310) 423-3302
Beth Y. Karlan, MD is Director of the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology and Director of the Gilda Radner Hereditary Cancer Program. She holds the Board of Governors Chair in gynecologic oncology. Dr. Karlan also is Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).
Board certified in obstetrics and gynecology and in gynecologic oncology, Dr. Karlan has been awarded research grants from such groups as the Department of Defense, National Institutes of Health and the American Cancer Society. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility.
Dr. Karlan has written over 150 peer reviewed articles, in publications, such as Gynecologic Oncology, Cancer, Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research. She served as an Editorial Board member for Obstetrics and Gynecology and Journal of Clinical Oncology and in 2008 was appointed Editor-in-Chief for Gynecologic Oncology.
Dr. Karlan's national leadership is exemplified by her position as President of the Society of Gynecologic Oncologists (2005-2006), a member of the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology and service on the Board of Governors of the American College of Surgeons. In 2006, Dr. Karlan was awarded the American Cancer Society, California Division - Early Detection Professorship.
Dr. Karlan is a magna cum laude graduate of Harvard-Radcliffe College. She earned her medical degree from Harvard Medical School and the Harvard-Massachusetts Institute of Technology Program in Health Sciences and Technology. After finishing her residency at Yale-New Haven Hospital, Dr. Karlan completed a postdoctoral research fellowship in molecular biology at Yale University School of Medicine and a clinical fellowship in gynecologic oncology at the David Geffen School of Medicine at UCLA.